Home LiteratureArticle Details
PMID: 30276263 Published · ppublish English Journal Article

Structural and Mechanistic Insights into the Catalytic-Domain-Mediated Short-Range Glycosylation Preferences of GalNAc-T4.

ACS central science ·Vol. 4 ·No. 9 ·2018-09-26 ·Pages 1274-1290

de Las Rivas M, Paul Daniel EJ, Coelho H, Lira-Navarrete E, Raich L, Compañón I, Diniz A, Lagartera L, Jiménez-Barbero J, Clausen H, Rovira C, Marcelo F, Corzana F, Gerken TA, Hurtado-Guerrero R

Abstract

Mucin-type O-glycosylation is initiated by a family of polypeptide GalNAc-transferases (GalNAc-Ts) which are type-II transmembrane proteins that contain Golgi luminal catalytic and lectin domains that are connected by a flexible linker. Several GalNAc-Ts, including GalNAc-T4, show both long-range and short-range prior glycosylation specificity, governed by their lectin and catalytic domains, respectively. While the mechanism of the lectin-domain-dependent glycosylation is well-known, the molecular basis for the catalytic-domain-dependent glycosylation of glycopeptides is unclear. Herein, we report the crystal structure of GalNAc-T4 bound to the diglycopeptide GAT*GAGAGAGT*TPGPG (containing two α-GalNAc glycosylated Thr (T*), the PXP motif and a "naked" Thr acceptor site) that describes its catalytic domain glycopeptide GalNAc binding site. Kinetic studies of wild-type and GalNAc binding site mutant enzymes show the lectin domain GalNAc binding activity dominates over the catalytic domain GalNAc binding activity and that these activities can be independently eliminated. Surprisingly, a flexible loop protruding from the lectin domain was found essential for the optimal activity of the catalytic domain. This work provides the first structural basis for the short-range glycosylation preferences of a GalNAc-T.

Authors & Affiliations
15 authors, click to expand affiliations / ORCID
de Las Rivas Matilde
BIFI, University of Zaragoza, BIFI-IQFR (CSIC) Joint Unit, Mariano Esquillor s/n, Campus Rio Ebro, Edificio I+D, Zaragoza 50018, Spain.
Paul Daniel Earnest James
Departments of Biochemistry, Pediatrics and Chemistry, Case Western Reserve University, Cleveland, Ohio 44106, United States.
Coelho Helena
UCIBIO, REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade de Nova de Lisboa, Caparica 2825-149, Portugal. | CIC bioGUNE, Bizkaia Technology Park, Building 801A, 48170 Derio, Spain. | Departament of Organic Chemistry II, Faculty of Science & Technology, University of the Basque Country, Leioa, 48940 Bizkaia, Spain.
Lira-Navarrete Erandi
Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, School of Dentistry, University of Copenhagen, Copenhagen 1165, Denmark.
Raich Lluis
Departament de Química Inorgànica i Orgànica (secció de Química Orgànica) & Institut de Química Teòrica i Computacional (IQTCUB), Universitat de Barcelona, Martí i Franquès 1, 08028 Barcelona, Spain.
Compañón Ismael
Departamento de Química, Universidad de La Rioja, Centro de Investigación en Síntesis Química, E-26006 Logroño, Spain.
Diniz Ana
UCIBIO, REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade de Nova de Lisboa, Caparica 2825-149, Portugal.
Lagartera Laura
Instituto de Química Médica, IQM-CSIC, 28006 Madrid, Spain.
Jiménez-Barbero Jesús
CIC bioGUNE, Bizkaia Technology Park, Building 801A, 48170 Derio, Spain. | Departament of Organic Chemistry II, Faculty of Science & Technology, University of the Basque Country, Leioa, 48940 Bizkaia, Spain. | Ikerbasque, Basque Foundation for Science, Maria Diaz de Haro 13, 48009 Bilbao, Spain.
Clausen Henrik
Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, School of Dentistry, University of Copenhagen, Copenhagen 1165, Denmark.
Rovira Carme
Departament de Química Inorgànica i Orgànica (secció de Química Orgànica) & Institut de Química Teòrica i Computacional (IQTCUB), Universitat de Barcelona, Martí i Franquès 1, 08028 Barcelona, Spain. | Institució Catalana de Recerca i Estudis Avançats (ICREA), Passeig Lluís Companys, 23, 08010 Barcelona, Spain.
Marcelo Filipa
UCIBIO, REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade de Nova de Lisboa, Caparica 2825-149, Portugal.
Corzana Francisco
Departamento de Química, Universidad de La Rioja, Centro de Investigación en Síntesis Química, E-26006 Logroño, Spain.
Gerken Thomas A
Departments of Biochemistry, Pediatrics and Chemistry, Case Western Reserve University, Cleveland, Ohio 44106, United States.
Hurtado-Guerrero Ramon
BIFI, University of Zaragoza, BIFI-IQFR (CSIC) Joint Unit, Mariano Esquillor s/n, Campus Rio Ebro, Edificio I+D, Zaragoza 50018, Spain. | Fundación ARAID, 50018 Zaragoza, Spain.
Conflict of Interest

The authors declare no competing financial interest.

References (43)
43 references, click to expand
  1. Serine versus threonine glycosylation: the methyl group causes a drastic alteration on the carbohydrate orientation and on the surrounding water shell.
    J Am Chem Soc. 2007 Aug 1;129(30):9458-67 PMID: 17616194
  2. Lectins as pattern recognition molecules: the effects of epitope density in innate immunity.
    Glycobiology. 2010 Mar;20(3):270-9 PMID: 19939826
  3. Expression of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase isoforms in murine tissues determined by real-time PCR: a new view of a large family.
    Glycobiology. 2003 Jul;13(7):549-57 PMID: 12651884
  4. The lectin domain of the polypeptide GalNAc transferase family of glycosyltransferases (ppGalNAc Ts) acts as a switch directing glycopeptide substrate glycosylation in an N- or C-terminal direction, further controlling mucin type O-glycosylation.
    J Biol Chem. 2013 Jul 5;288(27):19900-14 PMID: 23689369
  5. Fine-Tuning Limited Proteolysis: A Major Role for Regulated Site-Specific O-Glycosylation.
    Trends Biochem Sci. 2018 Apr;43(4):269-284 PMID: 29506880
  6. Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat.
    J Biol Chem. 1998 Nov 13;273(46):30472-81 PMID: 9804815
  7. Theory of Adaptive Optimization for Umbrella Sampling.
    J Chem Theory Comput. 2014 Jul 8;10(7):2719-2728 PMID: 25018672
  8. Substrate-guided front-face reaction revealed by combined structural snapshots and metadynamics for the polypeptide N-acetylgalactosaminyltransferase 2.
    Angew Chem Int Ed Engl. 2014 Jul 28;53(31):8206-10 PMID: 24954443
  9. Low density lipoprotein receptor class A repeats are O-glycosylated in linker regions.
    J Biol Chem. 2014 Jun 20;289(25):17312-24 PMID: 24798328
  10. Mucin-type O-glycosylation during development.
    J Biol Chem. 2013 Mar 8;288(10):6921-9 PMID: 23329828
  11. Glycopeptide-preferring polypeptide GalNAc transferase 10 (ppGalNAc T10), involved in mucin-type O-glycosylation, has a unique GalNAc-O-Ser/Thr-binding site in its catalytic domain not found in ppGalNAc T1 or T2.
    J Biol Chem. 2009 Jul 24;284(30):20387-97 PMID: 19460755
  12. Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation.
    J Biol Chem. 2006 Jul 7;281(27):18370-7 PMID: 16638743
  13. The lectin domain of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-T4 directs its glycopeptide specificities.
    J Biol Chem. 2000 Dec 8;275(49):38197-205 PMID: 10984485
  14. Overview of the CCP4 suite and current developments.
    Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42 PMID: 21460441
  15. Dynamic interplay between catalytic and lectin domains of GalNAc-transferases modulates protein O-glycosylation.
    Nat Commun. 2015 May 05;6:6937 PMID: 25939779
  16. Systematic determination of the peptide acceptor preferences for the human UDP-Gal:glycoprotein-alpha-GalNAc beta 3 galactosyltransferase (T-synthase).
    Glycobiology. 2009 Mar;19(3):321-8 PMID: 19073881
  17. Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.
    Glycobiology. 2012 Jun;22(6):736-56 PMID: 22183981
  18. Steered molecular dynamics and mechanical functions of proteins.
    Curr Opin Struct Biol. 2001 Apr;11(2):224-30 PMID: 11297932
  19. Structural basis of carbohydrate transfer activity by human UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase (pp-GalNAc-T10).
    J Mol Biol. 2006 Jun 9;359(3):708-27 PMID: 16650853
  20. Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases.
    J Biol Chem. 2011 Apr 22;286(16):14493-507 PMID: 21349845
  21. Mucin-type O-glycosylation is controlled by short- and long-range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase family.
    Glycobiology. 2016 Apr;26(4):360-76 PMID: 26610890
  22. Thermodynamics of multivalent carbohydrate-lectin cross-linking interactions: importance of entropy in the bind and jump mechanism.
    Biochemistry. 2009 May 12;48(18):3822-7 PMID: 19292456
  23. Dynamic association between the catalytic and lectin domains of human UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase-2.
    J Biol Chem. 2006 Mar 31;281(13):8613-9 PMID: 16434399
  24. The interdomain flexible linker of the polypeptide GalNAc transferases dictates their long-range glycosylation preferences.
    Nat Commun. 2017 Dec 5;8(1):1959 PMID: 29208955
  25. Conservation of peptide acceptor preferences between Drosophila and mammalian polypeptide-GalNAc transferase ortholog pairs.
    Glycobiology. 2008 Nov;18(11):861-70 PMID: 18669915
  26. Inhibitor of ppGalNAc-T3-mediated O-glycosylation blocks cancer cell invasiveness and lowers FGF23 levels.
    Elife. 2017 Mar 31;6: PMID: 28362263
  27. A proactive role of water molecules in acceptor recognition by protein O-fucosyltransferase 2.
    Nat Chem Biol. 2016 Apr;12(4):240-6 PMID: 26854667
  28. VMD: visual molecular dynamics.
    J Mol Graph. 1996 Feb;14(1):33-8, 27-8 PMID: 8744570
  29. The beginnings of mucin biosynthesis: the crystal structure of UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase-T1.
    Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15307-12 PMID: 15486088
  30. Loss of Function of GALNT2 Lowers High-Density Lipoproteins in Humans, Nonhuman Primates, and Rodents.
    Cell Metab. 2016 Aug 9;24(2):234-45 PMID: 27508872
  31. Water Sculpts the Distinctive Shapes and Dynamics of the Tumor-Associated Carbohydrate Tn Antigens: Implications for Their Molecular Recognition.
    J Am Chem Soc. 2018 Aug 8;140(31):9952-9960 PMID: 30004703
  32. Lectin domains of polypeptide GalNAc transferases exhibit glycopeptide binding specificity.
    J Biol Chem. 2011 Sep 16;286(37):32684-96 PMID: 21768105
  33. REFMAC5 for the refinement of macromolecular crystal structures.
    Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67 PMID: 21460454
  34. Organelle Specific O-Glycosylation Drives MMP14 Activation, Tumor Growth, and Metastasis.
    Cancer Cell. 2017 Nov 13;32(5):639-653.e6 PMID: 29136507
  35. The CCP4 suite: programs for protein crystallography.
    Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3 PMID: 15299374
  36. Identification of common and unique peptide substrate preferences for the UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferases T1 and T2 derived from oriented random peptide substrates.
    J Biol Chem. 2006 Oct 27;281(43):32403-16 PMID: 16912039
  37. Coot: model-building tools for molecular graphics.
    Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32 PMID: 15572765
  38. A systematic study of modulation of ADAM-mediated ectodomain shedding by site-specific O-glycosylation.
    Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14623-8 PMID: 26554003
  39. XDS.
    Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32 PMID: 20124692
  40. The catalytic and lectin domains of UDP-GalNAc:polypeptide alpha-N-Acetylgalactosaminyltransferase function in concert to direct glycosylation site selection.
    J Biol Chem. 2008 Aug 22;283(34):22942-51 PMID: 18562306
  41. The extended ppGalNAc-T family and their functional involvement in the metastatic cascade.
    Histol Histopathol. 2014 Mar;29(3):293-304 PMID: 24105335
  42. Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.
    Immunity. 2016 Jun 21;44(6):1444-54 PMID: 27332733
  43. The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation.
    Glycobiology. 2007 Apr;17(4):374-87 PMID: 17215257
Article Info
Journal
ACS central science
Abbr.
ACS Cent Sci
ISSN
2374-7943
Published
2018-09-26
Epub
2018-00-14
Pages
1274-1290
Language
English
Region
United States
NLM ID
101660035
PMCID
PMC6161044
Grants
NIGMS NIH HHS · R01 GM113534 · United States
NIGMS NIH HHS · U01 GM113534 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com